Clinical Trials · NCT01395940
A Randomized Open Label Study of KLH-2109 in Patients With Endometriosis(1)
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Enrollment
- 20
- Start date
- Not specified
- Locations
- 1 site, Japan
- Primary endpoint
- The severity score of the pelvic pain